KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Shares Outstanding (Diluted Average) (2016 - 2025)

CareDx (CDNA) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $53.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 5.89% to $53.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.3 million through Dec 2025, down 5.89% year-over-year, with the annual reading at $53.3 million for FY2025, 5.89% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $53.3 million in Q4 2025 for CareDx, down from $53.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $56.6 million in Q4 2024 to a low of $51.2 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $53.3 million across 5 years, with a median of $53.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 19.52% in 2021 and later fell 5.89% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $52.2 million in 2021, then rose by 2.07% to $53.3 million in 2022, then grew by 0.83% to $53.8 million in 2023, then grew by 5.31% to $56.6 million in 2024, then decreased by 5.89% to $53.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CDNA at $53.3 million in Q4 2025, $53.7 million in Q3 2025, and $54.3 million in Q2 2025.